Ko­re­an reg­u­la­tors shut down Sam­sung Phar­ma man­u­fac­tur­ing af­ter find­ing ad­di­tives, false records

South Ko­rea’s health reg­u­la­tor has sus­pend­ed Sam­sung Phar­ma­ceu­ti­cal’s man­u­fac­tur­ing op­er­a­tions un­til mid-Feb­ru­ary af­ter the agency learned that a pro­duc­tion man­ag­er was tasked with re­spon­si­bil­i­ties of two dif­fer­ent plants. The rev­e­la­tion vi­o­lat­ed a law re­quir­ing each plant to be man­aged by one per­son.

Mon­day’s halt comes just months af­ter an in­spec­tion re­vealed a num­ber of vi­o­la­tions at one Sam­sung Phar­ma plant, in­clud­ing the use of ad­di­tives with­out per­mis­sion and false man­u­fac­tur­ing records, the Ko­rea Bio­med­ical Re­view re­port­ed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER